Monget P, Monniaux D
INRA, Station de physiologie de la reproduction des mammifères domestiques, URA CNRS 1291, Nouzilly, France.
Contracept Fertil Sex. 1994 Sep;22(9):556-63.
The stimulating effect of Insulin-like Growth Factors (IGFs) on ovarian folliculogenesis is modulated by binding proteins (IGFBPs). During follicular growth, levels of IGFBP-2, -4 and -5 decrease in follicular fluid. These changes are a consequence of a decrease in synthesis and of a degradation by gonadotropin-stimulated specific proteases. They lead to an increase in the bioavailability of IGFs and their action on granulosa cells. By contrast, follicular atresia is characterized by a high increase in the synthesis and levels of IGFBPs < 40kDa, and by a dramatic decrease in IGFs bioavailability. Finally, at least part of intrafollicular IGFs and IGFBP-3 may be derived from the circulatory pool. Their levels only change slightly during follicular growth and atresia.